Pamela Shaw

Professor Dame Pam Shaw is Professor of Neurology at the University of Sheffield. She is also the director of the Sheffield Institute for Translational Neuroscience (SITraN), the NIHR Sheffield Biomedical Research Centre for Translational Neuroscience, the Sheffield Care and Research Centre for Motor Neuron Disorders and the cross- faculty Sheffield Neuroscience Institute. She is a Clinician Scientist in Neurology, formerly a Wellcome Trust Senior Fellow and currently an NIHR Senior Investigator. Her team investigates genetic, molecular and neurochemical mechanisms underlying ALS/MND. She investigates new therapeutic targets and translates new neuroprotective and symptomatic treatment approaches into the clinic. She has authored more than 500 publications which are highly cited by other academics. Her research is funded by the MRC, Wellcome Trust, NIHR, MNDA, EU and biotech/pharmaceutical industry partners. From 2009-2016 she led the UK Clinical Studies Group for ALS/MND, a clinical research and trials network which links 20 ALS/MND Care and Research Centres. Professor Shaw has taken part in more than 21 ALS clinical trials. She is an active member of the European Network for the Cure of ALS (ENCALS).